Acceler8 Ventures PLC
30 September 2026
30 September 2026
ACCELER8 VENTURES PLC
(the “Company” or"Ac8")
Total Voting Rights and Capital
In conformity with DTR 5.6.1R, the Company hereby announces that, as at 30 September 2026, the Company's issued share capital consisted of 758,912,252 Ordinary Shares.
There are no ordinary shares held in Treasury.
The total number of voting rights of the Company is 758,912,252 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
Enquiries:
|
Acceler8 Ventures Plc |
Daniel Levine Giles Willits
|
C/oFTI Consulting |
|
Joh. Berenberg, Gossler & Co. KG, London Branch |
Matthew Armitt Mark Whitmore Alex Wright
|
+44 (0)20 3207 7800 |
|
FTI Consulting |
John Waples Valerija Cymbal Jemima Gurney
|
+44 (0)20 3727 1000 AC8@fticonsulting.com
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.